Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: Effect on plasma transfusion therapy: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 1, 2011, Pages 3-7

  Matevosyan, Karén ^a   Madden, Christopher ^a   Barnett, Samuel L ^a   Beshay, Joseph E ^a   Rutherford, Cynthia ^a   Sarode, Ravindra ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Coagulation factor; International normalized ratio; Plasma; Prothrombin time; Transfusion

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; PROTHROMBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; NEUROSURGERY; PLASMA; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOPLASTIN TIME;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; ERYTHROCYTE TRANSFUSION; FACTOR VII; FACTOR VIII; FEMALE; HEMOSTASIS, SURGICAL; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PROTHROMBIN; PROTHROMBIN TIME;

EID: 78651284862     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.7.JNS091699     Document Type: Article

References (46)

1. Allford SL, Hunt BJ, Rose P, Machin SJ: Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 120:556-573, 2003
2. Anonymous: Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force of the College of American Pathologists. JAMA 271:777-781, 1994
3. Antovic J, Bakić M, Ignjatović G, Milenković Z, Djurić S, Tasić J, et al: Blood coagulation and fibrinolysis parameter changes after various types of brain damage. Facta Universitatis 5:44-49, 1998
4. Bernard RW, Stahl WM: Subclavian vein catheterizations: a prospective study. I. Non-infectious complications. Ann Surg 173:184-190, 1971
5. Boldt J, von Bormann B, Kling D, Jacobi M, Moosdorf R, Hempelmann G: Preoperative plasmapheresis in patients undergoing cardiac surgery procedures. Anesthesiology 72:282-288, 1990 (Pubitemid 20057995)
6. Catto AJ, Grant PJ: Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis. Blood Coagul Fibrinolysis 6:497-510, 1995
7. Cohen H: Avoiding the misuse of fresh frozen plasma. BMJ 307:395-396, 1993 (Pubitemid 23227461)
8. Consten EC, Henny CP, Eijsman L, Dongelmans DA, van Oers MH: The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg 112:162-167, 1996 (Pubitemid 26268983)
9. Contreras M, Ala FA, Greaves M, Jones J, Levin M, Machin SJ, et al: Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med 2:57-63, 1992
10. Cortese-Hassett A, Bontempo FA: The INR (International Normalized Ratio) for Monitoring Oral Anticoagulant Therapy. Transfusion Medicine Update: June, 1995
11. Davis JW, Davis IC, Bennink LD, Hysell SE, Curtis BV, Kaups KL, et al: Placement of intracranial pressure monitors: are "normal" coagulation parameters necessary? J Trauma 57:1173-1177, 2004
12. DeLoughery TG, Liebler JM, Simonds V, Goodnight SH: Invasive line placement in critically ill patients: do hemostatic defects matter? Transfusion 36:827-831, 1996
13. Dzik W, Rao A: Why do physicians request fresh frozen plasma? Transfusion 44:1393-1394, 2004
14. Dzik WH: Component therapy before bedside procedures, in Mintz PD (ed): Transfusion Therapy: Clinical Principles and Practice, ed 2. Bethesda, MD: American Association of Blood Banks, 2005, pp 1-26
15. Fisher NC, Mutimer DJ: Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit. Intensive Care Med 25:481-485, 1999
16. Gajic O, Dzik WH, Toy P: Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: benefit or harm? Crit Care Med 34 (5 Suppl):S170-S173, 2006
17. Gernsheimer T: Transfusion therapy: blood components and transfusion complications, in Irwin RS, Rippe JM (eds): Irwin and Rippe's Intensive Care Medicine, ed 5. Philadelphia: Lippincott Williams & Wilkins, 2003, p 1280
18. Gibson BE, Todd A, Roberts I, Pamphilon D, Rodeck C, Bolton-Maggs P, et al: Transfusion guidelines for neonates and older children. Br J Haematol 124:433-453, 2004
19. Günter P: Practice guidelines for blood component therapy. Anesthesiology 85:1219-1220, 1996
20. Holland L, Sarode R: Should plasma be transfused prophylactically before invasive procedures? Curr Opin Hematol 13:447-451, 2006 (Pubitemid 44607446)
21. Holland LL, Brooks JP: Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 126:133-139, 2006
22. Holness L, Knippen MA, Simmons L, Lachenbruch PA: Fatalities caused by TRALI. Transfus Med Rev 18:184-188, 2004
23. Horne MK III: Hemostatic testing and laboratory interpretation, in Kitchens CS, Alving BM, Kessler CM (eds): Consultative Hemostasis and Thrombosis, ed 1. Philadelphia: WB Saunders, 2002, pp 15-26
24. Kasper SM, Giesecke T, Limpers P, Sabatowski R, Mehlhorn U, Diefenbach C: Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery. Anesthesiology 95:81-86, 2001
25. Kleinman S, Chan P, Robillard P: Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 17:120-162, 2003
26. McClelland DB: Fresh frozen plasma-opinion and evidence. Transfus Med 2:97-98, 1992
27. Mumtaz H, Williams V, Hauer-Jensen M, Rowe M, Henry-Tillman RS, Heaton K, et al: Central venous catheter placement in patients with disorders of hemostasis. Am J Surg 180:503-506, 2000
28. O'Keefe G: Critical care and post injury management, in Mulholland MW, Lillomoe KD, Doherty GM, et al (eds): Greenfield's Surgery: Scientific Principles and Practice, ed 4. Philadelphia: Lippincott Williams & Wilkins, 2005, pp 493-501
29. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al: Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 126:11-28, 2004 (Pubitemid 38859478)
30. Oliver WC Jr, Beynen FM, Nuttall GA, Schroeder DR, Ereth MH, Dearani JA, et al: Blood loss in infants and children for open heart operations: albumin 5% versus fresh-frozen plasma in the prime. Ann Thorac Surg 75:1506-1512, 2003
31. Poller L: International Normalized Ratios (INR): the first 20 years. J Thromb Haemost 2:849-860, 2004
32. Roberts HR, Escobar MA: Less common congenital disorders of hemostasis, in Kitchens CS, Alving BM, Kessler CM (eds): Consultative Hemostasis and Thrombosis, ed 1. Philadelphia: WB Saunders, 2002, pp 57-74
33. Roberts HR, Monroe DM III, Hoffman M: Molecular biology of the coagulation factors and pathways of hemostasis, in Beutler E, Lichtman MA, Coller BS, et al (eds): Williams Hematology, ed 6. New York: McGraw-Hill, 2000, pp 1409-1434
34. Roseff SD, Luban NL, Manno CS: Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42:1398-1413, 2002
35. Segal JB, Dzik WH: Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45:1413-1425, 2005
36. Shore-Lesserson L, Spiess BD: Perioperative coagulation monitoring, in Spiess BD, Spence RK, Shander A (eds): Perioperative Transfusion Medicine, ed 2. Philadelphia: Lippincott Williams & Wilkins, 2006, pp 351-368
37. Smith TP, McDermott VG, Ayoub DM, Suhocki PV, Stackhouse DJ: Percutaneous transhepatic liver biopsy with tract embolization. Radiology 198:769-774, 1996
38. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF: Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol 126:139-152, 2004
39. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 104:3631-3634, 2004
40. Triulzi D: Blood Transfusion Therapy: A Physician's Hand book, ed 7. Bethesda, MD: American Association of Blood Banks, 2002
41. Wallace EL: Monitoring the nation's blood supply. Transfusion 43:299-301, 2003
42. Wallis JP, Dzik S: Is fresh frozen plasma overtransfused in the United States? Transfusion 44:1674-1675, 2004
43. WHO: WHO Expert Committee on Biological Standardization. Guidelines for Thromboplastins and Plasma Used to Control Oral Anticoagulant Therapy. WHO Technical Report Series no. 889. Geneva: WHO, 1999, pp 64-93
44. WHO: WHO Expert Committee on Biological Standardization. Thirty-third Report. Requirements for Thromboplastins and Plasma Used in Control Oral Anticoagulant Therapy. WHO Technical Report Series no. 687. Geneva: WHO, 1983, pp 81-105
45. Wilhelmi M, Franke U, Cohnert T, Weber P, Kaukemüller J, Fischer S, et al: Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur J Cardiothorac Surg 19:657-661, 2001 (Pubitemid 32416616)
46. Youssef WI, Salazar F, Dasarathy S, Beddow T, Mullen KD: Role of fresh frozen plasma infusion in correction of coagulop athy of chronic liver disease: a dual phase study. Am J Gastroenterol 98:1391-1394, 2003